Correlation Salivary Cortisol and Free Serum Cortisol to Total Serum Cortisol in MICU Septic Shock
NCT00523198 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2014-12-04
Summary
The purpose of the study is:
* to correlate salivary cortisol to free serum cortisol (as salivary cortisol is considered to be almost complete free cortisol) and,
* to correlate free serum cortisol to total serum cortisol levels
Both in patients with septic shock (severe sepsis requiring vasopressors).
We believe that:
* total serum cortisol does not correlate with free serum cortisol in patient with septic shock and,
* that salivary cortisol correlates with free serum cortisol and can be used to determine the level of free serum cortisol.
Conditions
- Septic Shock
Sponsors & Collaborators
-
The University of Texas Health Science Center, Houston
lead OTHER
Principal Investigators
-
Rosa M Estrada-Y-Martin, MD · The University of Texas-Health Science Center at Houston / Division of Pulmonary, Sleep and Critical Care Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2008-08-31
- Completion
- 2008-10-31
Countries
- United States
Study Locations
More Related Trials
-
Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock
NCT00005890 ·Status: COMPLETED ·Phase: NA
-
Early Versus Conventional Cessation of Hydrocortisone in Septic Shock
NCT05818826 ·Status: RECRUITING ·Phase: PHASE2
-
Cortisol Control of Human Inflammatory Responses to Endotoxin
NCT00396344 ·Status: COMPLETED ·Phase: NA
-
Proadrenomedullin and Copeptin in Patients With Septic Shock
NCT03104933 ·Status: COMPLETED
-
Natriuresis as a Predictor of the Haemodynamic Response to Steroid Replacement Therapy in Patients in Septic Shock
NCT03258619 ·Status: COMPLETED
-
Hemodynamic and Inflammatory Effects of Abrupt Versus Tapered Corticosteroid Discontinuation in Septic Shock
NCT01150409 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response in Septic Shock
NCT02069288 ·Status: WITHDRAWN ·Phase: PHASE3
-
Adrenal Insufficiency in Septic Shock
NCT00842933 ·Status: TERMINATED ·Phase: PHASE4
-
Fluid Responseveness in Sepsis and Its Correlation to CVP
NCT05612529 ·Status: TERMINATED
-
Evaluation of the Role of Hydrocortisone Either Alone or Combined With Fludrocortisone in the Outcome of Septic Shock in Adults
NCT04492280 ·Status: COMPLETED ·Phase: PHASE4
-
Gender-based Differences in the Outcome of the Treatment of Persistent Septic Shock With Hydrocortisone
NCT06537180 ·Status: COMPLETED
-
De-resuscitation Informed by Ultrasound for Patients With Sepsis
NCT04921319 ·Status: UNKNOWN ·Phase: NA
-
HCT+F vs. HCT Alone in Critically Ill Medical Septic Shock Patients
NCT03710187 ·Status: COMPLETED ·Phase: PHASE2
-
Fludrocortisone in Healthy Volunteers (AFLUCO4)
NCT02140918 ·Status: COMPLETED ·Phase: PHASE2
-
Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients
NCT07234526 ·Status: NOT_YET_RECRUITING
-
Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis
NCT00368381 ·Status: WITHDRAWN ·Phase: PHASE4
-
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
NCT03434028 ·Status: COMPLETED ·Phase: PHASE3
-
Steroids and Post-resuscitation Infectious (Septic) Complications
NCT02408939 ·Status: COMPLETED
-
Clinical Characteristics and Risk Factors for In-Hospital Mortality in Surgical Patients With Abdominal Sepsis
NCT06756750 ·Status: COMPLETED
-
Sodium Status in Septic Patients and Its Relation to Prognosis an Hospital Stay
NCT04564508 ·Status: UNKNOWN
-
The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients
NCT02306239 ·Status: UNKNOWN ·Phase: NA
-
VTE Incidence in Severe Sepsis and Septic Shock
NCT02353910 ·Status: COMPLETED
-
Timing of Preload Responsiveness in Sepsis
NCT05627817 ·Status: UNKNOWN
-
Mitochondrial Function in Septic Patients
NCT03748537 ·Status: COMPLETED ·Phase: NA
-
Hydrocortisone for Prevention of Septic Shock
NCT00670254 ·Status: COMPLETED ·Phase: PHASE3